Table 3.
RAS mutation | Tissue | Plasma | ||
---|---|---|---|---|
N | % | N | % | |
KRAS Exon 2 Codon 12 | 40 | 77 | 35 | 70 |
KRAS Exon 2 Codon 13 | 10 | 19 | 10 | 20 |
KRAS Exon 3 Codon 61 | 1 | 2 | 1 | 2 |
NRAS Exon 3 Codon 61 | 1 | 2 | 3 | 6 |
KRAS Exon 4 Codon 146 | 1 | 2 | 1 | 2 |
RAS prevalence | 52/98 = 53.1% | 50/98 = 51.0% | ||
WT prevalence | 46/98 = 46.9% | 48/98 = 49.0% |